Olerup SSP

What Olerup SSP does

Olerup SSP is the HLA-typing product line operated under the GenDx Laboratory Products brand (legal name: GenDx), a Stockholm, Sweden-based developer of in vitro diagnostic (IVD) reagents, kits, and companion software for transplant diagnostics. The company was founded in 1997 and operates as a small specialty IVD business with 11–50 employees, serving clinical laboratories and transplant centers that perform donor–recipient matching for hematopoietic stem cell and solid-organ transplantation.

The product platform is anchored on the legacy Olerup SSP HLA Typing Kits — qualitative IVD kits based on Sequence-Specific Primer (SSP) technology for DNA-based typing of HLA Class I and HLA Class II alleles. The portfolio has been deliberately expanded beyond the original SSP chemistry into adjacent technologies: QTYPE adds real-time PCR-based low-to-intermediate resolution HLA typing; AlloSeq HCT targets post-transplant chimerism monitoring; AlloSeq Tx uses hybrid-capture next-generation sequencing for genetic matching; AlloSeq cfDNA addresses cell-free DNA-based organ transplant surveillance; AlloSeq Nano and TruSight HLA v2 (co-developed with Illumina) round out the NGS and miniaturized assay formats. Two software modules — SCORE (standardized evaluation of SSP/QTYPE results) and Assign (sequence data import, base calling, editing, and HLA allele library comparison) — sit on top of the consumables, producing a kit-plus-software architecture where the analytical workflow is anchored to GenDx's own allele library.

The business model combines one-time IVD consumable sales with recurring software licensing (SCORE and Assign). Go-to-market is executed through a global distributor network for laboratory products, with direct-customer relationships maintained via the GenDx Lab Products website and login-protected technical resources. The customer base is verticalized around clinical HLA workflows: hospital and independent clinical laboratories performing transplant diagnostics are the primary segment, transplant centers are a co-primary user of chimerism and cfDNA monitoring, and clinical researchers conducting HLA studies using TruSight HLA constitute a secondary segment. No public pricing, revenue, or funding data is disclosed, and the company's investment history, ownership structure, and management team beyond a named CEO are not detailed in available sources.

Name

Olerup SSP

Legal name

GenDx

Website

https://olerup.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Olerup SSP, operated under the GenDx Laboratory Products brand, develops in vitro diagnostic HLA typing kits and companion analysis software for clinical laboratories and transplant centers performing donor–recipient matching and post-transplant monitoring.

Ownership category

akta.pro rank

Product category

Transplant Diagnostics & HLA Typing Reagents

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

Keywords

• HLA typing kits
• Transplant diagnostics
• Chimerism monitoring
• In vitro diagnostics
• Genetic matching reagents

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

1. Diagnostic Kit Sales: Sale of in vitro diagnostic kits including Olerup SSP HLA typing kits, AlloSeq product line, and QTYPE for transplant diagnostics.
2. Software Licensing: Licensing of companion software including SCORE and Assign for HLA typing analysis and evaluation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Olerup SSP develops and sells qualitative in vitro diagnostic kits and reagents for genomic HLA (Human Leukocyte Antigen) typing used in donor-recipient matching prior to bone marrow and solid organ transplantation. Its portfolio includes the Olerup SSP HLA Typing Kits, AlloSeq HCT for chimerism monitoring, AlloSeq Tx for genetic matching, AlloSeq cfDNA for organ transplant surveillance, QTYPE, TruSight HLA, and Olerup SBT, complemented by SCORE and Assign companion software for analysis.

Product overview

GenDx Laboratory Products offers a full suite of products for transplant patient diagnostic testing. The portfolio is organized as a platform-plus-modules architecture, featuring the core Olerup SSP HLA Typing Kits as a foundational product, complemented by AlloSeq HCT (chimerism monitoring), AlloSeq Tx (genetic matching with hybrid capture), AlloSeq cfDNA (organ transplant surveillance), AlloSeq Nano, QTYPE (HLA typing), and TruSight HLA v2 Sequencing Panel. Supporting software modules include SCORE (for standardized evaluation of HLA typing results with Olerup SSP kits and QTYPE) and Assign (for sequence data analysis, base calling, and editing).

Differentiator

Problem solved

Functional benefit

Brands

• AlloSeq HCT: Revolutionizing Chimerism Monitoring product for transplant patient diagnostic testing.
• AlloSeq Tx
• AlloSeq cfDNA
• QTYPE
• TruSight HLA
• SCORE
• Assign

Products and services

• Olerup SSP HLA Typing Kits Qualitative in vitro diagnostic kits for DNA-based typing of HLA Class I and HLA Class II alleles used in transplant compatibility testing prior to bone marrow and solid organ transplantation.
• AlloSeq HCT Chimerism monitoring technology for tracking donor-recipient cell populations after hematopoietic stem cell transplantation.
• AlloSeq Tx Next-generation genetic matching product utilizing hybrid capture technology for transplant compatibility assessment.
• AlloSeq cfDNA Cell-free DNA-based organ transplant surveillance for detecting graft rejection and driving better patient outcomes.
• QTYPE HLA typing at low to intermediate resolution for samples requiring fast turn-around-time with speed and precision.
• TruSight HLA v2 Sequencing Panel Sequencing panel designed for Illumina sequencers that provides clinical researchers with broad-coverage, high-resolution HLA typing for simple, rapid assessment of the HLA region in a single assay.
• Olerup SBT Sequencing-based typing (SBT) product for HLA analysis.
• AlloSeq Nano Diagnostic product for transplant patient testing.
• SCORE Software Standalone software tool to perform a standardized evaluation of HLA typing results generated with Olerup SSP kits and Olerup QTYPE real-time data.
• Assign Software Software that imports sequence data, performs base calling, enables sequence editing, and compares consensus sequences with a library of HLA alleles; includes workflows for TruSight HLA, AlloSeq, and SBT data analysis.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• IlluminacoreTechnology or IntegrationGenDx products including Olerup SSP integrate with Illumina sequencing platforms. The TruSight HLA v2 Sequencing Panel is specifically designed for Illumina sequencers, providing broad-coverage, high-resolution HLA typing solution. Software products like Assign include specific workflows for TruSight HLA data analysis.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• BAG Health Care: BAG Health Care is a German-based diagnostics company offering HLA typing kits and reagents, directly competing with Olerup SSP in the European transplant laboratory market with comparable SSP and SSO product lines.
• Immucor: Immucor manufactures transfusion and transplant diagnostics, including HLA typing reagents and serology products, making it a direct competitor in the HLA/transplant diagnostics market served by Olerup SSP.
• One Lambda (Thermo Fisher Scientific): One Lambda is the leading provider of HLA typing reagents and transplant diagnostics products, directly competing with Olerup SSP's SSP and NGS-based typing kits across the same clinical laboratory customer base; it is now part of Thermo Fisher Scientific following the 2012 acquisition.
• CareDx: CareDx is a transplant-focused diagnostics company whose AlloSure cfDNA-based rejection surveillance test directly competes with GenDx's AlloSeq cfDNA; it also offers HLA typing and chimerism products, overlapping with Olerup SSP's portfolio.
• Progenika (Grifols): Progenika, part of Grifols, provides HLA typing products including the OLERUP SSP product line complement and other transplant diagnostics, directly competing with GenDx in HLA typing reagents primarily across European and Latin American markets.

Emerging players

• HistoGenetics: HistoGenetics is a high-resolution HLA typing services provider that competes with the Olerup SSP-installed workflow by offering outsourced sequencing-based typing rather than kits; it overlaps with the same end-customer base of transplant centers and donor registries.
• Biofortuna: Biofortuna develops HLA diagnostics products, including point-of-care and lyophilized molecular typing assays, representing an emerging player with partial product overlap with Olerup SSP in the HLA typing kit category.
• Linkage BioSciences: Linkage BioSciences offers cell-free DNA-based transplant surveillance (e.g., DirectShot), competing with AlloSeq cfDNA in the post-transplant monitoring segment; it is a smaller emerging player in the same transplant diagnostics category.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher Scientific is a broad life sciences and diagnostics incumbent that owns One Lambda; it competes with GenDx through a comprehensive transplant and HLA diagnostics portfolio bundled with sequencing instruments and reagents, with much greater scale and reach.
• Illumina: Illumina is the dominant clinical sequencing platform provider and a strategic partner of GenDx via the TruSight HLA v2 panel; it is also a potential competitive threat as sequencing-centric HLA workflows could enable labs to consolidate testing onto Illumina-native solutions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olerup SSP